Core symptoms of depression : Effectiveness of antidepressant therapy;Depressive Kernsymptome : Wirksamkeit medikamentöser antidepressiver therapieverfahren

Nervenarzt

Volumn 80, Issue 5, 2009, Pages 515-531

  Damm, J ^a   Eser, D ^a   Schule C ^a   Moller H J ^a   Rupprecht, R ^a   Baghai, T C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Core symptoms; Depression; Melancholia; Pharmacological treatments; Subtypes

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM; LORAZEPAM; MONOAMINE OXIDASE INHIBITOR; PLACEBO; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; BIPOLAR DEPRESSION; CLINICAL FEATURE; COGNITIVE DEFECT; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DYSTHYMIA; EEG ABNORMALITY; ELECTROCONVULSIVE THERAPY; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR DEPRESSION; MELANCHOLIA; PSYCHIATRIC DIAGNOSIS; PSYCHOMOTOR DISORDER; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; DEPRESSION; HUMANS;

EID: 67349095760     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-008-2660-6     Document Type: Article

References (104)

1. Akiskal H, Bourgeois ML, Angst J et al (2000) Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 59 [Suppl 1]:5-30
2. Akiskal 2006 J Affect Disord 92 45
3. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. 4rd ed rev Washington DC
4. American Psychiatric Association Committee on Electroconvulsive Therapy, Weiner RD, Coffey CE et al (2001) The Practice of Electroconvulsive Therapy. American Psychiatric Association, Washington
5. Anderson IM (1998) SSRIS versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability. Depress Anxiety 7 [Suppl 1]:11-17
6. Anderson 2000 J Affect Disord 58 19
7. Andrews 1994 Am J Med 97 24S
8. Angst 2006 Can J Psychiatry 51 3
9. Angst 1985 Eur Arch Psychiatry Neurol Sci 234 408
10. Angst 2007 Acta Psychiatr Scand 115 72
11. Antiplatelet 1994 BMJ 308 81
12. Armitage 2007 Acta Psychiatr Scand 115 104
13. Azorin 2004 Encephale 30 158
14. Baghai 2008 Dialogues Clin Neurosci 10 309
15. Baghai 2008 Dialogues Clin Neurosci 10 105
16. Barkin 2005 Am J Ther 12 431
17. Bauer 2003 Can J Psychiatry 48 440
18. Bauer 2002 World J Biol Psychiatry 3 4
19. Bech 1981 Acta Psychiatr Scand 63 290
20. Birkenhager 2004 J Clin Psychiatry 65 87
21. Bolwig 2007 Acta Psychiatr Scand 115 130
22. Brown 2007 Acta Psychiatr Scand 115 125
23. Burke MJ, Preskorn SH (1995) Short term treatment of mood disorders with standard antidepressants. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The fourth generation of progress. Raven Press, New York, pp 1053-1065
24. Cassano 1988 Pharmacopsychiatry 21 19
25. Cipriani 2006 J Clin Psychiatry 67 850
26. Coryell W (1996) Psychotic depression. J Clin Psychiatry 57 [Suppl 3]:27-31
27. Coryell 2007 Acta Psychiatr Scand 115 31
28. Danish 1993 J Affect Disord 28 105
29. Drevets 2000 Biol Psychiatry 48 813
30. Duman RS (2002) Synaptic plasticity and mood disorders. Mol Psychiatry 7 [Suppl 1]:29-34
31. Duman 2006 Biol Psychiatry 59 1116
32. Fava 2002 J Clin Psychiatry 63 305
33. Fava M (2003) The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression. J Clin Psychiatry 64 [Suppl 13]:26-29
34. Fink 1990 Convuls Ther 6 1
35. Fink 1992 Convuls Ther 8 159
36. Fink 2007 Acta Psychiatr Scand 115 14
37. Fountoulakis 1999 Eur Psychiatry 14 426
38. Gendreau 2005 J Rheumatol 32 1975
39. Gijsman 2004 Am J Psychiatry 161 1537
40. Goldberg 2003 J Psychiatr Pract 9 181
41. Grunze 2002 World J Biol Psychiatry 3 115
42. Gupta 2003 Eur Arch Psychiatry Clin Neurosci 253 140
43. Hameed 2005 Ann Clin Psychiatry 17 77
44. Hamilton 1960 J Neurol Neurosurg Psychiatry 23 56
45. Hegerl 2004 MMW Fortschr Med 146 Spec No 2 10
46. Henkel 2006 Psychiatry Res 141 89
47. Henkel 2004 J Affect Disord 83 237
48. Judd 1998 Arch Gen Psychiatry 55 694
49. Kasper S (2001) Hypericum perforatum - a review of clinical studies. Pharmacopsychiatry 34 [Suppl 1]:51-55
50. Kasper 1990 J Affect Disord 18 211
51. Khan 2006 Ann Clin Psychiatry 18 91
52. Kirsch 2008 PLoS Med 5 e45
53. Laakmann G, Faltermaier-Temizel M, Bossert-Zaudig S, Baghai T (1996) Are benzodiazepines antidepressants? Psychopharmacology (Berl) 124:291-292
54. Laakmann G, Schule C, Baghai T, Kieser M (1998) St. John's wort in mild to moderate depression: The relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 31 [Suppl 1]:54-59
55. Lecrubier 2007 Eur Psychiatry 22 252
56. Leproult 2005 Clin Endocrinol 298
57. Loo 2002 Encephale 28 356
58. Loo 2003 Encephale 29 165
59. Mattia 2002 Minerva Anestesiol 68 105
60. Moller 2008 Eur Arch Psychiatry Clin Neurosci 258 451
61. Möller 2006 Eur Arch Psychiatry Clin Neurosci 256 1
62. Moller 2007 Nervenarzt 78 1014
63. Montgomery 1994 Eur Arch Psychiatry Clin Neurosci 244 211
64. Montgomery 1979 Br J Psychiatry 134 382
65. Montgomery 2007 Int Clin Psychopharmacol 22 323
66. Montgomery 2007 Int Clin Psychopharmacol 22 283
67. Mulsant 2001 J Clin Psychiatry 62 597
68. National Institute for Clinical Excellence (2004) Depression: Management of depression in primary and secondary care. http://www.Nice.Org.Uk/Pdf/ CG023quickrefguide.Pdf Clinical Guideline 23
69. National Institute of Mental Health (1976) 028 CGI. Clinical Global Impressions. In: Guy W, Bonato RR (eds) Manual for the EDCEU Assessment Battery, 2. Rev. Chevy Chase, Maryland, pp 12-1-12-6
70. Novick 2005 J Clin Psychiatry 66 1002
71. Pandi-Perumal SR, Trakht I, Srinivasan V et al (2008) Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways. Prog Neurobiol
72. Parker 2007 Acta Psychiatr Scand 115 21
73. Patten 2006 Can J Psychiatry 51 6
74. Peet 1994 Br J Psychiatry 164 549
75. Pezawas 2005 Int Rev Psychiatry 17 63
76. Pezawas 2001 Nervenarzt 72 169
77. Praschak-Rieder 1997 J Clin Psychiatry 58 389
78. Price 1983 Am J Psychiatry 140 318
79. Riemann 2002 Pharmacopsychiatry 35 165
80. Rocca 2002 J Affect Disord 70 313
81. Rohland 1993 J Affect Disord 29 255
82. Rosenthal 1985 Am J Psychiatry 142 163
83. Saarto T, Wiffen PJ (2005) Antidepressants for neuropathic pain. Cochrane Database Syst Rev CD005454
84. Sachs 1994 J Clin Psychiatry 55 391
85. Sartorius N, Baghai TC, Baldwin DS et al (2007) Antidepressant medications and other treatments of depressive disorders: A CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol 10 [Suppl 1]:1-207
86. Schüle C, Baghai TC, Rupprecht R (2007) New insights into the pathogenesis and pathophysiology of depression. Nervenarzt 78 [Suppl 3]:531-547
87. Shelton 2007 Int Clin Psychopharmacol 22 348
88. Shorter 2007 Acta Psychiatr Scand 115 5
89. Simon 1999 N Engl J Med 341 1329
90. Sogaard 1999 J Psychopharmacol 13 406
91. Starkstein 1996 J Neurol Neurosurg Psychiatry 60 326
92. Steinmeyer 1992 J Affect Disord 25 53
93. Stewart 2007 Acta Psychiatr Scand 115 58
94. Taylor 2003 Am J Psychiatry 160 1233
95. Thase ME (1999) Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry 60 [Suppl 17]:28-31
96. Tran 2003 J Clin Psychopharmacol 23 78
97. Uebelhack 2004 Adv Ther 21 265
98. Volz 2000 Compr Psychiatry 41 133
99. World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland
100. World Health Organization (2005) Depression. WHO Report on Mental Health http://www.who.int/mental-health/management/depression/definition/en/
101. Yatham 2005 Psychiatr Clin North Am 28 325
102. Zanardi 1996 Am J Psychiatry 153 1631
103. Zanardi 1997 Int Clin Psychopharmacol 12 195
104. Zanardi R, Smeraldi E (2005) A double-blind, randomised, controlled clinical trial of acetyl-l-carnitine vs. amisulpride in the treatment of dysthymia. Eur Neuropsychopharmacol